HIV

Seeking a cure for HIV

Efforts to find a cure for HIV were reinvigorated in 2008 when the case of Timothy Ray Brown showed that a cure is possible. Researchers and pharmaceutical companies are now seeking out the virus in its hiding places in an attempt to eradicate it completely.…

How Ana Martinez helped tackle the HIV epidemic

Pharmacist Ana Martinez explains how involving pharmacists in HIV clinical trials earned her the highest honour from the International Pharmaceutical Federation.…

NICE says Truvada is effective as PrEP but identifies issues to consider

The National Institute for Health and Care Excellence has published a summary of evidence for the use of Truvada as pre-exposure prophylaxis against HIV in adults at high risk of infection.…

First drug licenced in Europe for pre-exposure prophylaxis against HIV

The European Commission has approved the first drug for pre-exposure prophylaxis (PrEP) against HIV for use in Europe following a positive recommendation by the European Medicines Agency (EMA) in July 2016. Gilead Sciences has been granted a licence to market emtricitabine/tenofovir disoproxil…

NHS England may commission PrEP for HIV if its appeal fails

NHS England has set out how it plans to commission pre-exposure prophylaxis (PrEP) for HIV if it fails in its bid to overturn a High Court ruling that says commissioning the treatment does fall within its powers. …

Ending the AIDS epidemic by 2030: can it be done?

Luiz Loures from the Joint United Nations Programme on HIV/AIDS (UNAIDS) talks about ending the epidemic, and the challenges in fighting the disease that has claimed over 34 million lives.…

NHS England continues to add insult to injury with regard to PrEP funding

On 2 August 2016, the National AIDS Trust (NAT) won its judicial review of NHS England’s removal of pre-exposure prophylaxis (PrEP), the highly effective HIV prevention drug, from its commissioning process. The judge ruled that NHS England was wrong to assert that it cannot fund PrEP because i…

High Court says NHS England was wrong to say it could not fund PrEP

A High Court judge has ruled that NHS England was wrong to decide that it cannot fund a “game changing” drug that can prevent HIV infection.…

EMA recommends approval of Truvada as HIV pre-exposure prophylaxis

The first drug for HIV pre-exposure prophylaxis has been recommended for approval across the EU.…

New global HIV infections plateau at 2.6 million per year

The number of people who have become infected with HIV has stayed at around 2.6 million each year over the past decade, new figures reveal.…